Federal Register / Vol. 86, No. 33 / Monday, February 22, 2021 / Notices 10589 

public or otherwise would be more 

limited in scope than the activities such 

service member, employees, contractors, 

or volunteers are authorized to carry out 

under this declaration. 

Amendments to the Declaration, 

section 2, Effective Time Period, section 

XII; the sentence is corrected to read: 

‘‘add to the end of the section: Liability 

protections for Qualified Persons under 

section V(h) of the declaration begin on 

February 16, 2021, and last through 

October 1, 2024. 

Wilma Robinson, 

Deputy Executive Secretary, U.S. Department 

of Health and Human Services. 

[FR Doc. 2021–03526 Filed 2–19–21; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0955–0003] 

Agency Father Generic Information 

Collection Request. 60-Day Public 

Comment Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before April 23, 2021. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202) 795–7714. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0955–0003– 

60D, and project title for reference, to 

Sherrette Funn, the Reports Clearance 

Officer, Sherrette.funn@hhs.gov, or call 

202–795–7714. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Generic 

Clearance for the Collection of 

Qualitative Feedback on Agency Service 

Delivery. 

Type of Collection: Father Generic 

ICR. 

OMB No. 0955–0003—Office of the 

National Coordinator for Health 

Information Technology. 

Abstract: The Office of the National 

Coordinator for Health Information 

Technology is seeking a three-year 

extension of OMB control number 

0955–0003 to continue collecting 

routine customer feedback on agency 

service delivery. The proposed 

information collection activity provides 

a means to garner qualitative customer 

and stakeholder feedback in an efficient, 

timely manner, in accordance with the 

Administration’s commitment to 

improving service delivery. Qualitative 

feedback means information that 

provides useful insights on perceptions 

and opinions, and is not statistical 

surveys that yield quantitative results 

that can be generalized to the 

population of study. This feedback will 

provide insights into customer or 

stakeholder perceptions, experiences, 

and expectations; provide an early 

warning of issues with the service; or 

focus attention on areas where 

communication, training, or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative, 

and actionable communications 

between the Agency and its customers 

and stakeholders. It will also allow 

feedback to contribute directly to the 

improvement of program management. 

The solicitation of feedback will target 

areas such as timeliness, 

appropriateness, accuracy of 

information, courtesy, efficiency of 

service delivery, and resolution of 

issues with service delivery. Responses 

will be assessed to plan and inform 

efforts to improve or maintain the 

quality of service offered to the public. 

If this information is not collected, vital 

feedback from customers and 

stakeholders on the Agency’s services 

will be unavailable. 

Affected Public: Individuals, 

households, professionals, and/or the 

public/private sector. 

Average estimates for the next three 

years: 

Estimated Total Number of 

Respondents: 10,000. 

Expected Annual Number of 

Activities: 6. 

Average Number of Respondents per 

Activity: 1,667. 

Frequency of Response: Once per 

Activity. 

Average Minutes per Response: 7. 

Total Burden Hours: 1,167. 

ANNUALIZED BURDEN HOUR TABLE

Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

Total burden 

hours 

10,000 .......................................................................................................................................... 1 7/60 1,167 

Total ...................................................................................................................................... ........................ ........................ 1,167 

Dated: February 10, 2021. 

Sherrette A. Funn, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 2021–03531 Filed 2–19–21; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 


tkelley on DSKBCP9HB2PROD with NOTICES
10590 Federal Register / Vol. 86, No. 33 / Monday, February 22, 2021 / Notices 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Drug Discovery, Neurodegenerative 

Disorders and Modeling. 

Date: March 19, 2021. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Vanessa S. Boyce, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 4185, 

MSC 7850, Bethesda, MD 20892, (301) 402– 

3726, boycevs@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Drug Development & 

Therapeutics (CDDT). 

Date: March 22–23, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Psychopathology, Substance 

Abuse, and Community-Based Interventions 

Across the Lifespan. 

Date: March 23, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Elia K. Ortenberg, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3108, 

MSC 7816, Bethesda, MD 20892, (301) 827– 

7189, femiaee@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Psychopathology, Substance 

Abuse, and Community-Based Interventions 

Across the Lifespan. 

Date: March 23, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David Erik Pollio, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 1006F, 

Bethesda, MD 20892, 301–594–4002, 

polliode@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-Viral Anti-Infective 

Therapeutics. 

Date: March 23, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Bidyottam Mittra, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, Bethesda, MD 20894, 301.435.0000, 

bidyottam.mittra@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: SBIR/STTR Commercialization 

Readiness Pilot (CRP) Program. 

Date: March 23, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Allen Richon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6184, 

MSC 7892, Bethesda, MD 20892, 301–379– 

9351, allen.richon@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Pulmonary Diseases. 

Date: March 23–24, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: George M. Barnas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4220, 

MSC 7818, Bethesda, MD 20892, 301–435– 

0696, barnasg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery Involving the 

Nervous System. 

Date: March 23–24, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lai Yee Leung, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1011D 

Bethesda, MD 20892, (301) 435–1042, 

leungl2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–19– 

326: Reducing Stigma to Improve HIV/AIDS 

Prevention, Treatment and Care in Low- and 

Middle-Income Countries. 

Date: March 23, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Janetta Lun, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room1007E, 

Bethesda, MD 20892, 301–443–3655, 

janetta.lun@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–19– 

326: Reducing Stigma to Improve HIV/AIDS 

Prevention, Treatment and Care in Low- and 

Middle-Income Countries. 

Date: March 23, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marc Boulay, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, (301) 300– 

6541, boulaymg@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 17, 2021. 

Ronald J. Livingston, Jr., 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03525 Filed 2–19–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; CURE Research 

Consortium Review. 

Date: March 17–18, 2021. 


tkelley on DSKBCP9HB2PROD with NOTICES